Tumor tissues in patients with pancreatic ductal adenocarcinoma expressed a lower level of PER-1 and CRY2, which also predicts the poor OS of patients with pancreatic ductal adenocarcinoma 44. Here, CRY2 is linked to pancreatic ductal adenocarcinoma.